News
COVID, Moderna and flu vaccine
Digest more
This update covers the latest health sector developments, including Moderna's COVID-19 vaccine review, GSK's asthma drug FDA ...
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Pharmalittle: We’re reading about Trump’s drug-pricing plan, a Moderna change of plans, and more
The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.
4d
Investor's Business Daily on MSNModerna Reverses Its Rally As It Faces Another Vaccine SetbackModerna stock toppled Wednesday after the company withdrew its application for a combination Covid and flu vaccine.
5d
Barchart on MSNModerna Is the Largest Barchart’s Bottom 100 Stocks to Buy—But Size Alone Isn’t a Reason to InvestIt’s hard to believe Moderna (MRNA)once had a market cap exceeding $204 billion. That was in August 2021 at or near the ...
Explore more
Results that may be inaccessible to you are currently showing.
Hide inaccessible results